PI3K signaling controls cell fate at many points in B lymphocyte development and activation

Seminars in Cell and Developmental Biology

Volumn 15, Issue 2, 2004, Pages 183-197

  Donahue, Amber C ^a   Fruman, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1 Phosphatidylinositol 3 kinase; B lymphocyte; PI3K; Second messenger; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD40 ANTIGEN; CYTOKINE RECEPTOR; FC RECEPTOR; ISOPROTEIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TOLL LIKE RECEPTOR;

B LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL TYPE; HUMAN; MODEL; NONHUMAN; REGULATORY MECHANISM; REVIEW;

EID: 1342321748     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2003.12.024     Document Type: Article

References (131)

1. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C.et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:2001;535-602.
2. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell. Dev. Biol. 17:2001;615-675.
3. Fruman D.A., Meyers R.E., Cantley L.C. Phosphoinositide kinases. Annu. Rev. Biochem. 67:1998;481-507.
4. Musacchio A., Cantley L.C., Harrison S.C. Crystal structure of the breakpoint cluster region-homology domain from phosphoinositide 3-kinase p85 alpha subunit. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14373-14378.
5. Tolias K.F., Cantley L.C., Carpenter C.L. Rho family GTPases bind to phosphoinositide kinases. J. Biol. Chem. 270:1995;17656-17659.
6. Walker E.H., Perisic O., Ried C., Stephens L., Williams R.L. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature. 402:1999;220-313.
7. Welch H.C., Coadwell W.J., Ellson C.D., Ferguson G.J., Andrews S.R., Erdjument-Bromage H.et al. P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell. 108:2002;809-821.
8. Weiner O.D. Rac activation: P-Rex1 - a convergence point for PIP(3) and Gbetagamma? Curr. Biol. 12:2002;R429-R431.
9. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer. 2:2002;489-501.
10. Kishimoto H., Hamada K., Saunders M., Backman S., Sasaki T., Nakano T.et al. Physiological functions of pten in mouse tissues. Cell. Struct. Funct. 28:2003;11-21.
11. Rohrschneider L.R., Fuller J.F., Wolf I., Liu Y., Lucas D.M. Structure, function, and biology of SHIP proteins. Genes Dev. 14:2000;505-520.
12. Franke T.F., Kaplan D.R., Cantley L.C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 275:1997;665-668.
13. Gold M.R., Aebersold R. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells. J. Immunol. 152:1994;42-50.
14. Aagaard-Tillery K.M., Jelinek D.F. Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. J. Immunol. 156:1996;4543-4554.
15. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W.et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science. 283:1999;393-397.
16. Astoul E., Watton S., Cantrell D. The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell. Biol. 145:1999;1511-1520.
17. Costello P.S., Gallagher M., Cantrell D.A. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3:2002;1082-1089.
18. Cariappa A., Pillai S. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14:2002;241-249.
19. Hardy R.R. B-cell commitment: deciding on the players. Curr. Opin. Immunol. 15:2003;158-165.
20. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T.et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science. 283:1999;390-392.
21. Jou S.T., Carpino N., Takahashi Y., Piekorz R., Chao J.R., Wang D.et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol. Cell. Biol. 22:2002;8580-8591.
22. Okkenhaug K., Bilancio A., Farjot G., Priddle H., Sancho S., Peskett E. et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science. 297:2002;1031-1034.
23. Clayton E., Bardi G., Bell S.E., Chantry D., Downes C.P., Gray A.et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196:2002;753-763.
24. Fujimoto M., Poe J.C., Inaoki M., Tedder T.F. CD19 regulates B lymphocyte responses to transmembrane signals. Semin. Immunol. 10:1998;267-277.
25. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:1995;39-50.
26. Anzelon A.N., Wu H., Rickert R.C. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4:2003;287-294.
27. Suzuki A., Kaisho T., Ohishi M., Tsukio-Yamaguchi M., Tsubata T., Koni P.A.et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J. Exp. Med. 197:2003;657-667.
28. Ravetch J.V., Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19:2001;275-290.
29. Brauweiler A., Tamir I., Dal Porto J., Benschop R.J., Helgason C.D., Humphries R.K.et al. Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5′ inositol phosphatase (SHIP). J. Exp. Med. 191:2000;1545-1554.
30. Liu Q., Oliveira-Dos-Santos A.J., Mariathasan S., Bouchard D., Jones J., Sarao R.et al. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J. Exp. Med. 188:1998;1333-1342.
31. Lewis R.S. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 19:2001;497-521.
32. Buhl A.M., Cambier J.C. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162:1999;4438-4446.
33. 2+ oscillatory response. J. Immunol. 161:1998;5129-5132.
34. Venkatachalam K., van Rossum D.B., Patterson R.L., Ma H.T., Gill D.L. The cellular and molecular basis of store-operated calcium entry. Nat. Cell. Biol. 4:2002;E263-E272.
35. Fruman D.A., Satterthwaite A.B., Witte O.N. Xid-like phenotypes: a B cell signalosome takes shape. Immunity. 13:2000;1-3.
36. Koyasu S. The role of PI3K in immune cells. Nat. Immunol. 4:2003;313-319.
37. 2+ mobilization through distinct pathways. EMBO J. 13:1994;1341-1349.
38. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G. et al. Defective B cell development and function in Btk-deficient mice. Immunity. 3:1995;283-299.
39. Turner M., Mee P.J., Costello P.S., Williams O., Price A.A., Duddy L.P. et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 378:1995;298-302.
40. Torres R.M., Flaswinkel H., Reth M., Rajewsky K. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science. 272:1996;1804-1808.
41. Jumaa H., Wollscheid B., Mitterer M., Wienands J., Reth M., Nielsen P.J. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity. 11:1999;547-554.
42. Pappu R., Cheng A.M., Li B., Gong Q., Chiu C., Griffin N.et al. Requirement for B cell linker protein (BLNK) in B cell development. Science. 286:1999;1949-1954.
43. Hayashi K., Nittono R., Okamoto N., Tsuji S., Hara Y., Goitsuka R.et al. The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2755-2760.
44. Xu S., Tan J.E., Wong E.P., Manickam A., Ponniah S., Lam K.P. B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice. Int. Immunol. 12:2000;397-404.
45. Wang D., Feng J., Wen R., Marine J.C., Sangster M.Y., Parganas E.et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity. 13:2000;25-35.
46. Doody G.M., Bell S.E., Vigorito E., Clayton E., McAdam S., Tooze R.et al. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat. Immunol. 2:2001;542-547.
47. Tedford K., Nitschke L., Girkontaite I., Charlesworth A., Chan G., Sakk V.et al. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nat. Immunol. 2:2001;548-555.
48. Croker B.A., Tarlinton D.M., Cluse L.A., Tuxen A.J., Light A., Yang F.C.et al. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J. Immunol. 168:2002;3376-3386.
49. Walmsley M.J., Ooi S.K., Reynolds L.F., Smith S.H., Ruf S., Mathiot A.et al. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science. 302:2003;459-462.
50. Yamazaki T., Takeda K., Gotoh K., Takeshima H., Akira S., Kurosaki T. Essential immunoregulatory role for BCAP in B cell development and function. J. Exp. Med. 195:2002;535-545.
51. Satterthwaite A.B., Li Z., Witte O.N. Btk function in B cell development and response. Semin. Immunol. 10:1998;309-316.
52. Minegishi Y., Rohrer J., Coustan-Smith E., Lederman H.M., Pappu R., Campana D.et al. An essential role for BLNK in human B cell development. Science. 286:1999;1954-1957.
53. Fruman D.A., Cantley L.C. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14:2002;7-18.
54. Deane JA, Fruman, DA. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004, in press.
55. O'Rourke L.M., Tooze R., Turner M., Sandoval D.M., Carter R.H., Tybulewicz V.L.et al. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity. 8:1998;635-645.
56. Saito K., Tolias K.F., Saci A., Koon H.B., Humphries L.A., Scharenberg A.et al. BTK regulates PtdIns-4,5-P(2) synthesis. Importance for calcium signaling and PI3K activity. Immunity. 19:2003;669-677.
57. Takata M., Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J. Exp. Med. 184:1996;31-40.
58. Law C.L., Chandran K.A., Sidorenko S.P., Clark E.A. Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol. Cell. Biol. 16:1996;1305-1315.
59. Li Z., Wahl M.I., Eguinoa A., Stephens L.R., Hawkins P.T., Witte O.N. Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13820-13825.
60. Hashimoto S., Iwamatsu A., Ishiai M., Okawa K., Yamadori T., Matsushita M.et al. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood. 94:1999;2357-2364.
61. Aman M.J., Ravichandran K.S. A requirement for lipid rafts in B cell receptor induced Ca(2+) flux. Curr. Biol. 10:2000;393-396.
62. Cheng P.C., Dykstra M.L., Mitchell R.N., Pierce S.K. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190:1999;1549-1560.
63. Inabe K., Ishiai M., Scharenberg A.M., Freshney N., Downward J., Kurosaki T. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195:2002;189-200.
64. Guo B., Kato R.M., Garcia-Lloret M., Wahl M.I., Rawlings D.J. Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity. 13:2000;243-253.
65. Janssen E., Zhu M., Zhang W., Koonpaew S. LAB: a new membrane-associated adaptor molecule in B cell activation. Nat. Immunol. 4:2003;117-123.
66. Su T.T., Rawlings D.J. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168:2002;2101-2110.
67. Martin F., Kearney J.F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 12:2000;39-49.
68. Ellmeier W., Jung S., Sunshine M.J., Hatam F., Xu Y., Baltimore D.et al. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J. Exp. Med. 192:2000;1611-1624.
69. Beitz L.O., Fruman D.A., Kurosaki T., Cantley L.C., Scharenberg A.M. SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J. Biol. Chem. 274:1999;32662-32666.
70. Otero D.C., Omori S.A., Rickert R.C. Cd19-dependent activation of Akt kinase in B-lymphocytes. J. Biol. Chem. 276:2001;1474-1478.
71. Okada T., Maeda A., Iwamatsu A., Gotoh K., Kurosaki T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity. 13:2000;817-827.
72. Wang Y., Brooks S.R., Li X., Anzelon A.N., Rickert R.C., Carter R.H. The physiologic role of CD19 cytoplasmic tyrosines. Immunity. 17:2002;501-514.
73. Zheng Y., Bagrodia S., Cerione R.A. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J. Biol. Chem. 269:1994;18727- 18730.
74. Han J., Luby-Phelps K., Das B., Shu X., Xia Y., Mosteller R.D.et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 279:1998;558-560.
75. Liu Y., Rohrschneider L.R. The gift of Gab. FEBS Lett. 515:2002;1-7.
76. Gu H., Saito K., Klaman L.D., Shen J., Fleming T., Wang Y.et al. Essential role for Gab2 in the allergic response. Nature. 412:2001;186-190.
77. Gu H., Botelho R.J., Yu M., Grinstein S., Neel B.G. Critical role for scaffolding adapter Gab2 in Fc{gamma}R-mediated phagocytosis. J. Cell. Biol. 161:2003;1151-1161.
78. Ingham R.J., Santos L., Dang-Lawson M., Holgado-Madruga M., Dudek P., Maroun C.R.et al. The Gab1 docking protein links the B cell antigen receptor to the phosphatidylinositol 3-kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase. J. Biol. Chem. 276:2001;12257-12265.
79. Itoh S., Itoh M., Nishida K., Yamasaki S., Yoshida Y., Narimatsu M.et al. Adapter molecule Grb2-associated binder 1 is specifically expressed in marginal zone B cells and negatively regulates thymus-independent antigen-2 responses. J. Immunol. 168:2002;5110-5116.
80. Lynch D.K., Daly R.J. PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J. 21:2002;72-82.
81. Pratt J.C., Igras V.E., Maeda H., Baksh S., Gelfand E.W., Burakoff S.J. et al. Cutting edge: gab2 mediates an inhibitory phosphatidylinositol 3′-kinase pathway in T cell antigen receptor signaling. J. Immunol. 165:2000;4158-4163.
82. Yamasaki S., Nishida K., Hibi M., Sakuma M., Shiina R., Takeuchi A.et al. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules. J. Biol. Chem. 276:2001;45175-45183.
83. Arron J.R., Vologodskaia M., Wong B.R., Naramura M., Kim N., Gu H.et al. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J. Biol. Chem. 276:2001;30011-30017.
84. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33:2003;597-605.
85. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N.et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 1:2000;533-540.
86. Zamorano J., Wang H.Y., Wang L.M., Pierce J.H., Keegan A.D. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157:1996;4926-4934.
87. Venkitaraman A.R., Cowling R.J. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the alpha chain of the interleukin-7 receptor. Eur. J. Immunol. 24:1994;2168-2174.
88. Reedijk M., Liu X., van d.G.P., Letwin K., Waterfield M.D.T.H. Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J. 11:1992;1365-1372.
89. Serve H., Hsu Y.C., Besmer P. Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. J. Biol. Chem. 269:1994;6026-6030.
90. Lemmon M.A., Ferguson K.M. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350(Pt 1):2000;1-18.
91. Saito K., Scharenberg A.M., Kinet J.P. Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk. J. Biol. Chem. 276:2001;16201-16206.
92. Suzuki H., Matsuda S., Terauchi Y., Fujiwara M., Ohteki T., Asano T.et al. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 4:2003;280-286.
93. Okkenhaug K., Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3:2003;317-330.
94. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S.et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1998;1961-1972.
95. 2+ mobilization in antigen-stimulated mast cells. J. Leukoc. Biol. 65:1999;321-329.
96. Bae Y.S., Cantley L.G., Chen C.S., Kim S.R., Kwon K.S., Rhee S.G. Activation of phospholipase C-gamma by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:1998;4465-4469.
97. Rameh L.E., Rhee S.G., Spokes K., Kazlauskas A., Cantley L.C., Cantley L.G. Phosphoinositide 3-kinase regulates phospholipase Cgamma-mediated calcium signaling. J. Biol. Chem. 273:1998;23750-23757.
98. Falasca M., Logan S.K., Lehto V.P., Baccante G., Lemmon M.A., Schlessinger J. Activation of phospholipase Cgamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17:1998;414-422.
99. Forssell J., Nilsson A., Sideras P. Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4. Scand. J. Immunol. 49:1999;155-161.
100. Glassford J., Soeiro I., Skarell S.M., Banerji L., Holman M., Klaus G.G.et al. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene. 22:2003;2248-2259.
101. Leitges M., Schmedt C., Guinamard R., Davoust J., Schaal S., Stabel S.et al. Immunodeficiency in protein kinase cbeta-deficient mice. Science. 273:1996;788-791.
102. Bajpai U.D., Zhang K., Teutsch M., Sen R., Wortis H.H. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J. Exp. Med. 191:2000;1735-1744.
103. Petro J.B., Rahman S.M., Ballard D.W., Khan W.N. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J. Exp. Med. 191:2000;1745-1754.
104. Saijo K., Mecklenbrauker I., Santana A., Leitger M., Schmedt C., Tarakhovsky A. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. J. Exp. Med. 195:2002;1647-1652.
105. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A.et al. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:2002;780-786.
106. Yamazaki T., Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat. Immunol. 4:2003;780-786.
107. Fruman D.A., Ferl G.Z., An S.S., Donahue A.C., Satterthwaite A.B., Witte O.N. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 99:2002;359-364.
108. Andjelic S., Hsia C., Suzuki H., Kadowaki T., Koyasu S., Liou H.C. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways. J. Immunol. 165:2000;3860-3867.
109. Li H.L., Davis W.W., Whiteman E.L., Birnbaum M.J., Pure E. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6890-6895.
110. Bone H., Williams N.A. Antigen-receptor cross-linking and lipopolysaccharide trigger distinct phosphoinositide 3-kinase-dependent pathways to NF-kappa B activation in primary B cells. Int. Immunol. 13:2001;807-816.
111. Aman M.J., Lamkin T.D., Okada H., Kurosaki T., Ravichandran K.S. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J. Biol. Chem. 273:1998;33922-33928.
112. Deane JA, Trifilo MJ, Yballe CM, Choi S, Lane TE, Fruman DA. Enhanced T cell proliferation in mice lacking the p85b subunit of phosphoinositide 3-kinase. Submitted for publication.
113. Burgering B.M., Kops G.J. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci. 27:2002;352-360.
114. Yusuf I., Fruman D.A. Regulation of quiescence in lymphocytes. Trends Immunol. 24:2003;380-386.
115. Christian S.L., Sims P.V., Gold M.R. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3. J. Immunol. 169:2002;758-769.
116. Yusuf I, Zhu X, Kharas MG, Fruman DA. Optimal B cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Submitted for publication.
117. Kane L.P., Mollenauer M.N., Xu Z., Turck C.W., Weiss A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol. Cell. Biol. 22:2002;5962-5974.
118. Gold M.R., Scheid M.P., Santos L., Dang-Lawson M., Roth R.A., Matsuuchi L.et al. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J. Immunol. 163:1999;1894-1905.
119. Toker A., Newton A.C. Cellular signaling: pivoting around PDK-1. Cell. 103:2000;185-188.
120. Alessi D.R., Kozlowski M.T., Weng Q.P., Morrice N., Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8:1998;69-81.
121. Li H.L., Davis W., Pure E. Suboptimal cross-linking of antigen receptor induces Syk-dependent activation of p70S6 kinase through protein kinase C and phosphoinositol 3-kinase. J. Biol. Chem. 274:1999;9812-9820.
122. Donahue A.C., Fruman D.A. Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J. Immunol. 170:2003;5851-5860.
123. Niiro H., Maeda A., Kurosaki T., Clark E.A. The B lymphocyte adaptor molecule of 32. kDa (Bam32) regulates B cell antigen receptor signaling and cell survival J. Exp. Med. 195:2002;143-149.
124. Han A., Saijo K., Mecklenbrauker I., Tarakhovsky A., Nussenzweig M.C. Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. Immunity. 19:2003;621-632.
125. Fournier E., Isakoff S.J., Ko K., Cardinale C.J., Inghirami G.G., Li Z. et al. The B Cell SH2/PH domain-containing adaptor Bam32/DAPP1 is required for T cell-independent II antigen responses. Curr. Biol. 13:2003;1858-1866.
126. Jones S.M., Klinghoffer R., Prestwich G.D., Toker A., Kazlauskas A. PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr. Biol. 9:1999;512-521.
127. Grumont R.J., Strasser A., Gerondakis S. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Mol. Cell. 10:2002;1283-1294.
128. Tang T.T., Dowbenko D., Jackson A., Toney L., Lewin D.A., Dent A.L.et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J. Biol. Chem. 277:2002;14255-14265.
129. Perez O.D., Kinoshita S., Hitoshi Y., Payan D.G., Kitamura T., Nolan G.P.et al. Activation of the PKB/AKT pathway by ICAM-2. Immunity. 16:2002;51-65.
130. Harriague J., Bismuth G. Imaging antigen-induced PI3K activation in T cells. Nat. Immunol. 3:2002;1090-1096.
131. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A.V., Wu D. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science. 287:2000;1046-1049.